Genovis AB (publ.)
SSE:GENO.ST
43.5 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 158.232 | 102.387 | 93.018 | 61.03 | 60.549 | 34.568 | 22.867 | 18.542 | 13.269 | 8.252 | 8.912 | 6.081 | 2.856 | 1.596 | 0.986 | 0.38 |
Cost of Revenue
| 104.231 | 15.018 | 11.729 | 3.432 | 4.414 | 0.833 | 1.049 | 1.059 | 2.459 | 3.43 | 1.691 | 2.425 | 7.565 | 0.795 | 1.093 | 1.256 |
Gross Profit
| 54.001 | 87.369 | 81.289 | 57.598 | 56.135 | 33.735 | 21.819 | 17.483 | 10.809 | 4.822 | 7.221 | 3.656 | -4.709 | 0.801 | -0.107 | -0.876 |
Gross Profit Ratio
| 0.341 | 0.853 | 0.874 | 0.944 | 0.927 | 0.976 | 0.954 | 0.943 | 0.815 | 0.584 | 0.81 | 0.601 | -1.649 | 0.502 | -0.108 | -2.308 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 21.966 | 18.657 | 16.995 | 13.577 | 14.631 | 26.007 | 21.493 | 12.583 | 11.679 | 9.382 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 14.631 | 0 | 0 | 0 | 0 | 0 | 0 | 5.991 | 4.863 | 8.067 |
SG&A
| 79.349 | 68.193 | 21.966 | 18.657 | 16.995 | 13.577 | 14.631 | 26.007 | 21.493 | 12.583 | 11.679 | 9.382 | 0 | 5.991 | 4.863 | 8.067 |
Other Expenses
| 88.197 | 73.65 | 38.215 | 34.661 | 25.633 | 19.187 | 0.393 | 12.044 | 14.185 | 13.185 | 11.35 | 10.626 | 9.037 | 6.044 | 7.584 | 16.477 |
Operating Expenses
| 88.197 | 73.65 | 60.182 | 53.317 | 42.628 | 32.764 | 29.654 | 38.051 | 35.678 | 25.768 | 23.029 | 20.008 | 9.037 | 12.035 | 12.447 | 24.544 |
Operating Income
| 54.001 | 22.49 | 24.543 | 6.887 | 13.524 | -0.961 | -7.835 | -14.77 | -19.824 | -20.471 | -15.986 | -20.182 | -13.746 | -11.234 | -12.554 | -25.42 |
Operating Income Ratio
| 0.341 | 0.22 | 0.264 | 0.113 | 0.223 | -0.028 | -0.343 | -0.797 | -1.494 | -2.481 | -1.794 | -3.319 | -4.813 | -7.038 | -12.73 | -66.956 |
Total Other Income Expenses Net
| 0.849 | -14.495 | 0.06 | -4.738 | -3.856 | -2.571 | -0.091 | 5.666 | 5.01 | 0.615 | -0.106 | -3.809 | -0.012 | -0.1 | -0.215 | -0.153 |
Income Before Tax
| 54.85 | 7.995 | 24.604 | 2.149 | 9.668 | -1.6 | -7.926 | -14.902 | -19.858 | -20.331 | -15.914 | -20.162 | -13.758 | -11.334 | -12.769 | -25.572 |
Income Before Tax Ratio
| 0.347 | 0.078 | 0.265 | 0.035 | 0.16 | -0.046 | -0.347 | -0.804 | -1.497 | -2.464 | -1.786 | -3.316 | -4.817 | -7.101 | -12.948 | -67.358 |
Income Tax Expense
| -6.65 | -3.195 | -0.174 | -4.297 | 0.116 | 0.11 | 0.022 | 0.129 | 0.048 | 1.718 | -0.062 | -0.246 | -0.15 | -0.042 | 4.789 | 1.577 |
Net Income
| 61.5 | 11.191 | 24.777 | 6.446 | 9.552 | -1.71 | -7.949 | -15.031 | -19.906 | -22.049 | -15.853 | -19.915 | -13.608 | -11.292 | -17.558 | -27.15 |
Net Income Ratio
| 0.389 | 0.109 | 0.266 | 0.106 | 0.158 | -0.049 | -0.348 | -0.811 | -1.5 | -2.672 | -1.779 | -3.275 | -4.765 | -7.075 | -17.804 | -71.512 |
EPS
| 0.94 | 0.17 | 0.38 | 0.099 | 0.15 | -0.028 | -0.14 | -0.32 | -0.66 | -0.97 | -0.76 | -1.33 | -1.54 | -2.15 | -7.61 | -17.28 |
EPS Diluted
| 0.94 | 0.17 | 0.38 | 0.099 | 0.15 | -0.028 | -0.14 | -0.32 | -0.66 | -0.96 | -0.76 | -1.33 | -1.54 | -2.15 | -7.61 | -17.28 |
EBITDA
| 63.723 | 29.122 | 27.089 | 12.32 | 17.021 | 6.102 | -6.226 | -18.574 | -23.482 | -19.04 | -14.799 | -14.948 | -12.432 | -10.13 | -11.302 | -18.449 |
EBITDA Ratio
| 0.403 | 0.284 | 0.291 | 0.202 | 0.281 | 0.177 | -0.272 | -1.002 | -1.77 | -2.307 | -1.661 | -2.458 | -4.353 | -6.347 | -11.46 | -48.593 |